Masser Frye Genetic Screening 11.17.11

Masser Frye Genetic Screening 11.17.11 - Diane Masser-Frye,...

Info iconThis preview shows pages 1–15. Sign up to view the full content.

View Full Document Right Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon

Info iconThis preview has intentionally blurred sections. Sign up to view the full version.

View Full DocumentRight Arrow Icon
This is the end of the preview. Sign up to access the rest of the document.

Unformatted text preview: Diane Masser-Frye, MS, MSW, CGC Rady Childrens Hospital, San Diego Testing individuals to determine who is at risk of developing or transmitting a particular disease in order to ameliorate or prevent later disease. The rationale is that benefits of early detection exceed those possible if detection is deferred Disease should be severe A high-risk population can be identified There is an inexpensive, sensitive and specific test for the disease or carrier state More specific tests can confirm or rule out the diagnosis or carrier state Realistic and effective intervention is possible for those affected Pre-Implantation Prenatal Newborn Carrier Whole genome Direct-To-Consumer (DTC) Screens embryos for genetic conditions prior to transfer to the uterus Traditionally done for couples at risk for a particular genetic condition Now done to detect aneuploidy in many IVF cycles Recommended dosage for all women is 400 micrograms (0.4 milligrams) daily Pregnant women, or those planning to conceive, should get 800 micrograms daily About 30% of women of child-bearing age regularly take vitamins 50% of pregnancies are unplanned U.S. FDA mandated in 1996 that all enriched grain products should be fortified by 1998 Studies show 25-30% decrease in the rate of neural tube defects in the U.S. since fortification began Increasing the level of fortification could result in up to 70-80% decrease...
View Full Document

Page1 / 49

Masser Frye Genetic Screening 11.17.11 - Diane Masser-Frye,...

This preview shows document pages 1 - 15. Sign up to view the full document.

View Full Document Right Arrow Icon
Ask a homework question - tutors are online